Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Diabet Med ; 37(11): 1825-1831, 2020 11.
Article in English | MEDLINE | ID: mdl-31479537

ABSTRACT

AIMS: To evaluate whether and what combinations of diabetes quality metrics were achieved in a multicentre trial in South Asia evaluating a multicomponent quality improvement intervention that included non-physician care coordinators to promote adherence and clinical decision-support software to enhance physician practices, in comparision with usual care. METHODS: Using data from the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) trial, we evaluated the proportions of trial participants achieving specific and combinations of five diabetes care targets (HbA1c <53 mmol/mol [7%], blood pressure <130/80 mmHg, LDL cholesterol <2.6 mmol/L, non-smoking status, and aspirin use). Additionally, we examined the proportions of participants achieving the following risk factor improvements from baseline: ≥11-mmol/mol (1%) reduction in HbA1c , ≥10-mmHg reduction in systolic blood pressure, and/or ≥0.26-mmol/l reduction in LDL cholesterol. RESULTS: Baseline characteristics were similar in the intervention and usual care arms. Overall, 12.3%, 29.4%, 36.5%, 19.5% and 2.2% of participants in the intervention group and 16.2%, 38.3%, 31.6%, 11.3% and 0.8% of participants in the usual care group achieved any one, two, three, four or five targets, respectively. We noted sizeable improvements in HbA1c , blood pressure and cholesterol, and found that participants in the intervention group were twice as likely to achieve improvements in all three indices at 12 months that were sustained over 28 months of the study [relative risk 2.1 (95% CI 1.5,2.8) and 1.8 (95% CI 1.5,2.3), respectively]. CONCLUSIONS: The intervention was associated with significantly higher achievement of and greater improvements in composite diabetes quality care goals. However, among these higher-risk participants, very small proportions achieved the complete group of targets, which suggests that achievement of multiple quality-of-care goals is challenging and that other methods may be needed in closing care gaps.


Subject(s)
Decision Support Systems, Clinical , Diabetes Mellitus, Type 2/therapy , Quality Improvement , Quality Indicators, Health Care , Aspirin/therapeutic use , Blood Pressure , Cholesterol, LDL/metabolism , Delivery of Health Care/organization & administration , Diabetes Mellitus, Type 2/metabolism , Glycated Hemoglobin/metabolism , Humans , India , Pakistan , Platelet Aggregation Inhibitors/therapeutic use , Quality of Health Care , Smoking/epidemiology
2.
Diabet Med ; 35(12): 1644-1654, 2018 12.
Article in English | MEDLINE | ID: mdl-30142228

ABSTRACT

AIMS: To describe physicians' acceptance of decision-support electronic health record system and its impact on diabetes care goals among people with Type 2 diabetes. METHODS: We analysed data from participants in the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) trial, who received the study intervention (care coordinators and use of a decision-support electronic health record system; n=575) using generalized estimating equations to estimate the association between acceptance/rejection of decision-support system prompts and outcomes (mean changes in HbA1c , blood pressure and LDL cholesterol) considering repeated measures across all time points available. We conducted in-depth interviews with physicians to understand the benefits, challenges and value of the decision-support electronic health record system and analysed physicians' interviews using Rogers' diffusion of innovation theory. RESULTS: At end-of-trial, participants with diabetes for whom glycaemic, systolic blood pressure, diastolic blood pressure and LDL cholesterol decision-support electronic health record prompts were accepted vs rejected, experienced no reduction in HbA1c [mean difference: -0.05 mmol/mol (95% CI -0.22, 0.13); P=0.599], but statistically significant improvements were observed for systolic blood pressure [mean difference: -11.6 mmHg (95% CI -13.9, -9.3); P ≤ 0.001], diastolic blood pressure [mean difference: -5.2 mmHg (95% CI -6.5, -3.8); P ≤ 0.001] and LDL cholesterol [mean difference: -0.7 mmol/l (95% CI -0.6, -0.8); P ≤0.001], respectively. The relative advantages and compatibility of the decision-support electronic health record system with existing clinic set-ups influenced physicians' acceptance of it. Software complexities and data entry challenges could be overcome by task-sharing. CONCLUSION: Wider adherence to decision-support electronic health record prompts could potentially improve diabetes goal achievement, particularly when accompanied by assistance from a non-physician health worker.


Subject(s)
Clinical Trials as Topic , Decision Support Systems, Clinical , Electronic Health Records , Guideline Adherence/statistics & numerical data , Patient Care Planning , Physicians , Adult , Asia/epidemiology , Attitude of Health Personnel , Clinical Trials as Topic/methods , Clinical Trials as Topic/organization & administration , Decision Making , Decision Support Systems, Clinical/organization & administration , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/therapy , Diabetic Angiopathies/prevention & control , Electronic Health Records/organization & administration , Female , Humans , Male , Middle Aged , Patient Care Planning/organization & administration , Physicians/psychology , Physicians/statistics & numerical data , Primary Health Care/methods , Primary Health Care/organization & administration , Primary Health Care/statistics & numerical data , Risk Reduction Behavior
3.
Oncogene ; 36(41): 5681-5694, 2017 10 12.
Article in English | MEDLINE | ID: mdl-28604746

ABSTRACT

In many cancer types, integrin-mediated signaling regulates proliferation, survival and invasion of tumorigenic cells. However, it is still unclear how integrins crosstalk with oncogenes to regulate tumorigenesis and metastasis. Here we show that oncogenic K-RasV12 upregulates α6-integrin expression in Madin-Darby canine kidney (MDCK) cells via activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK)/Fos-related antigen 1-signaling cascade. Activated α6-integrins promoted metastatic capacity and anoikis resistance, and led to perturbed growth of MDCK cysts. Transcriptomic analysis of K-RasV12-transformed MDCK cells also revealed robust downregulation of αV-class integrins. Re-expression of αV-integrin in K-RasV12-transformed MDCK cells synergistically upregulated the expression of Zinc finger E-box-binding homeobox 1 and Twist-related protein 1 and triggered epithelial-mesenchymal transition leading to induced cell motility and invasion. These results delineate the signaling cascades connecting oncogenic K-RasV12 with α6- and αV-integrin functions to modulate cancer cell survival and tumorigenesis, and reveal new possible strategies to target highly oncogenic K-RasV12 mutants.


Subject(s)
Epithelial-Mesenchymal Transition/genetics , Integrin alphaV/genetics , Neoplasms/genetics , Proto-Oncogene Proteins c-fos/genetics , Animals , Anoikis/genetics , Cell Proliferation/genetics , Dogs , Humans , Integrin alpha6/genetics , Madin Darby Canine Kidney Cells , Neoplasms/pathology , Proto-Oncogene Proteins p21(ras)/genetics
5.
Article in English | MEDLINE | ID: mdl-15309282

ABSTRACT

We report a case of vesicocervical fistula secondary to caesarean section. This is a rare complication of caesarean section, which was not recognised intraoperatively. Diagnosis was made clinically, radiologically and endoscopically during the post-operative period. Conservative management with indwelling catheterisation for 3 weeks failed. Hence the fistula was repaired surgically by an abdominal approach.


Subject(s)
Cesarean Section/adverse effects , Fistula/etiology , Urinary Bladder Fistula/etiology , Uterine Diseases/etiology , Adult , Cystoscopy , Emergency Treatment , Female , Fistula/diagnosis , Fistula/surgery , Humans , Hysterectomy , Postoperative Care/methods , Pregnancy , Urinary Bladder Fistula/diagnosis , Urinary Bladder Fistula/surgery , Urogenital Surgical Procedures , Urography , Uterine Diseases/diagnosis , Uterine Diseases/surgery
7.
BJU Int ; 84(6): 637-9, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10510107

ABSTRACT

OBJECTIVE: To audit the results of combined transurethral resection of the prostate (TURP) and inguinal hernia repair, often carried out under the same anaesthetic (because bladder outlet obstruction from prostatic disease and inguinal hernia are both common conditions in elderly men), to avoid two separate operations. PATIENTS AND METHODS: The study included 85 patients who underwent primary inguinal hernia repair with TURP in the urology unit of Nottingham City hospital between 1989 and 1995, and who were recalled to a special clinic. The type of hernia and repair carried out were recorded and complications audited with specific reference to recurrence of hernia and wound infection. RESULTS: The 85 patients underwent 88 primary inguinal hernia repairs with TURP (three were bilateral). Maloney's darn repair was used on 55 and a Bassini repair on 33 occasions, respectively. Two patients developed mild wound infection after surgery, but only two patients (2%) had recurrence of hernia. CONCLUSIONS: The recurrence rate after primary inguinal herniorraphy with conventional methods of repair, performed with TURP, was comparable with published results of hernia repairs alone, before the introduction of Lichtenstein's mesh repair.


Subject(s)
Hernia, Inguinal/surgery , Prostatectomy/methods , Prostatic Diseases/surgery , Adult , Aged , Aged, 80 and over , Hernia, Inguinal/complications , Humans , Male , Middle Aged , Prostatic Diseases/complications , Recurrence , Retrospective Studies
8.
Br J Urol ; 82(3): 342-7, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9772868

ABSTRACT

OBJECTIVE: To assess the success of holmium:YAG lasertripsy in the management of ureteric calculi and to audit the complications of the procedure, with special reference to strictures in the ureter. PATIENTS AND METHODS: A total of 300 ureteroscopic laser procedures were carried out on 265 patients (204 male and 61 female, median age 51 years, range 2-95) with ureteric calculi. At ureteroscopy, the calculi were present in the upper ureter in 44%, mid-ureter in 37% and lower ureter in 19% of patients; most calculi were > 5 mm. A 7.5 F Wolf semi-rigid ureteroscope was used and the holmium:YAG laser energy delivered using the Sharplan ML210 device at 0.8-1.0 J/pulse. The patients were followed up at approximately 6 weeks with limited intravenous urography or ultrasonography to assess clearance and the incidence of strictures. RESULTS: Stones were completely cleared in 90% of the patients, with the best results in the lower and mid-ureter (97% and 96%, respectively) followed by the upper ureter (89%). Alternative procedures were required in only 17 (7%) patients; extracorporeal shock-wave lithotripsy in 13, percutaneous nephrolithotomy in two and open pyelolithotomy in two patients. Complications with ureteric perforation in 11 patients, including laparotomy for peritonitis in one, serious sepsis in two and strictures in 10 patients. Strictures were more common in association with impacted calculi in the upper ureter early in the series. CONCLUSIONS: Holmium:YAG lasertripsy is a highly effective treatment for ureteric calculi, with strictures related to the treatment of difficult upper ureteric calculi.


Subject(s)
Lithotripsy, Laser/methods , Ureteral Calculi/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Lithotripsy, Laser/adverse effects , Male , Middle Aged , Ureteral Obstruction/etiology
10.
J Rehabil Res Dev ; 28(4): 39-46, 1991.
Article in English | MEDLINE | ID: mdl-1941648

ABSTRACT

The Department of Computer Science at North Carolina State University, with support from the Department of Veterans Affairs and National Aeronautics and Space Administration (NASA) Langley Research Center, has developed an interactive graphics program for the development of shoe lasts from digitized images of feet or digitized images of commercial shoe lasts. The program runs on a Sun 3/260 computer with a TAAC-1 graphics accelerator. The program contains operations for region addition and deletion, techniques for narrowing the ankle area, methods for toe extension, operations to allow for shoe inserts, etc. Once the operations by the user are complete, the program will resample the resulting last in a 512 x 512 array. The user is then allowed to select an error tolerance which will guide a data reduction program to represent the last as Coons patches. These patches are then transmitted to a milling machine which will cut the last.


Subject(s)
Computer Graphics , Orthotic Devices , Shoes , Equipment Design , Software , User-Computer Interface
SELECTION OF CITATIONS
SEARCH DETAIL
...